Full Text | PDF

Share on facebook Share on tweeters Share on linkedin Share on googleplus

Int J Biol Sci 2021; 17(6):1538-1546. doi:10.7150/ijbs.59547 This issue Cite

Review

Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery

Yao Chen1,*, Mei-Xiu Li1,*, Guo-Dong Lu2, Han-Ming Shen3,4,✉, Jing Zhou1,4,✉

1. Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.
2. Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, Guangxi Province, China, 530021.
3. Faculty of Health Sciences, University of Macau, Taipa, Macau, China
4. Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
* These authors contributed equally to this work.

✉ Corresponding authors: Jing Zhou, Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, P.R. China. E-mail address: gardenia_zhoucom, ORCID: 0000-0002-2475-7783. Han-Ming Shen, Faculty of Health Sciences, Uni More

Citation:
Chen Y, Li MX, Lu GD, Shen HM, Zhou J. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery. Int J Biol Sci 2021; 17(6):1538-1546. doi:10.7150/ijbs.59547. https://www.ijbs.com/v17p1538.htm
Other styles

File import instruction

Abstract

Graphic abstract

The outbreak of coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. One major challenge in the battle against this deadly disease is to find effective therapy. Due to the availability and proven clinical record of hydroxychloroquine (HCQ) and chloroquine (CQ) in various human diseases, there have been enormous efforts in repurposing these two drugs as therapeutics for COVID-19. To date, substantial amount of work at cellular, animal models and clinical trials have been performed to verify their therapeutic potential against COVID-19. However, neither lab-based studies nor clinical trials have provided consistent and convincing evidence to support the therapeutic value of HCQ/CQ in the treatment of COVID-19. In this mini review we provide a systematic summary on this important topic and aim to reveal some truth covered by the mystery regarding the therapeutic value of HCQ/CQ in COVID-19.

Keywords: COVID-19, SARS-CoV-2, HCQ, CQ, therapy, clinical trials

Citation styles

APA
Chen, Y., Li, M.X., Lu, G.D., Shen, H.M., Zhou, J. (2021). Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery. International Journal of Biological Sciences, 17(6), 1538-1546. https://doi.org/10.7150/ijbs.59547.

ACS
Chen, Y.; Li, M.X.; Lu, G.D.; Shen, H.M.; Zhou, J. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery. Int. J. Biol. Sci. 2021, 17 (6), 1538-1546. DOI: 10.7150/ijbs.59547.

NLM
Chen Y, Li MX, Lu GD, Shen HM, Zhou J. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery. Int J Biol Sci 2021; 17(6):1538-1546. doi:10.7150/ijbs.59547. https://www.ijbs.com/v17p1538.htm

CSE
Chen Y, Li MX, Lu GD, Shen HM, Zhou J. 2021. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery. Int J Biol Sci. 17(6):1538-1546.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2025 Ivyspring International Publisher. Terms of use